19th SpR Epilepsy Teaching Weekend

11-12 May 2024

  • 00Days
  • 00Hours
  • 00Minutes
  • 00Seconds

Angelini Pharma

Angelini Pharma is an international pharmaceutical company, part of the Italian privately-owned Angelini Industries. The company has several manufacturing sites making pharmaceutical intermediates and medicines.

We are committed to helping patients in the therapeutic areas of Brain Health and Consumer Healthcare.

Angelini Pharma operates directly in 20 countries employing almost 3,000 people and commercialises its products in more than 70 countries through strategic alliances with other leading international pharmaceutical groups.

Further information about products available in the UK can be found at

UK23275P | April 2024


UCB is a global biopharmaceutical company dedicated to discovering and developing treatments that aim to transform the lives of people living with neurological and immunological conditions.

Because there is no such thing as an ‘average patient’ we use the tools, channels and scientific advances at our disposal to develop a deep understanding of a disease and the real needs of patients.

Working in collaboration with leading researchers from academia, medical charities and industry we strive to deliver cutting-edge science, innovative drugs and practical solutions patients need to improve their quality of life.

We are inspired by patients. Driven by science.

April 2024, IE-BR-2400073

UCB have provided funding towards the cost of running the meeting but have had no input into the agenda or content.